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Selling Sanity Through Gender: The
Psychodynamics of Psychotropic Advertising
Jonathan M. Metzl1,2
This paper provides a brief visual history of the ways women patients, and specif-
ically women patients whose marital status is identified in conjunction with their
“illness,” have been constructed as abnormal in the images of advertisements
designed to promote psychotropic medications to an audience of psychiatrists.
The advertisements I discuss come from the two largest circulation American psy-
chiatric journals,The American Journal of Psychiatryand Archives of General
Psychiatry, between the years 1964 and 2001. I use the ads to focus on two con-
comitant narratives. On one hand, I show how the advertisements situate the rise
of “wonder drugs” in the context of an era described as the “golden age of psy-
chopharmacology,” during which time drug treatments helped revolutionize the
diagnosis and treatment of anxiety, depression, and other outpatient mental ill-
nesses in the United States. On the other hand, the advertisements also illustrate the
ways in which these new scientific treatments could not function free of the culture
in which they were given meaning. In the space between drug and wonder drug, or
between medication and metaphor, the images thus hint at the ways psychotropic
treatments becameimbricatedwith the same gendered assumptions at play in an
American popular culture intimately concerned with connecting “normal” and
“heteronormal” when it came to defining the role of women in “civilization.”
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Women are uniquely vulnerable to institutional pressures toward defining
their problems in medical terms.
Nathanson, “Social Roles and Health Status Among Women,” 1980
Pharmaceutical marketing is the last element of an information continuum,
where research concepts are transformed into practical therapeutic tools and
where information is progressively layered and made more useful to the health
care system.
Levy, “The Role and Value of Pharmaceutical Marketing,” 1994
In 1999, the marketers of Prozac began a new advertising campaign on
the back covers of many leading psychiatric journals. A seemingly simple car-
toon backboard, innocently framed in blue and green, is shown against a light
golden background. An orange basketball, its trajectory marked in a narrative of
red, bounces off of the rim and begins its descent. Above and below the image, in
white text, we learn that “Sue’s playing with her kids again.. . . just like normal.”
What does normal mean? According to an Eli Lilly representative who visited
the hospital where I work, “‘Normal’ means Sue has returned to enjoying life. She
was depressed, but now because of Prozac she can play basketball with her children
just like she used to.”3 There is, it seems, no real need to consider the specifics
of this exceedingly vague message, nor wonder about the story it tells. Sue could
be any woman; the realm of the “normal” simultaneously full of meaning and
completely empty of specific content. This directive is perfectly conveyed by the
advertisement’s disembodied image—a backboard with no supporting pole, a jump
shot with no shooter, a “normal” with no apparent referent—designed to appeal
to atemporal, ahistorical postmodern sensibilities that are the products of an age
when disconnect is a national aesthetic, and Keith Haring is a corporate logo. Sue is
neither Madonna nor whore,4 not housewife, sex object, ethereal, caricatured, nor
naked; neither is she a viable woman, nor even a viable character.5 W thus need
not worry about her history and her history is in any way preempted by Prozac.
Sue, however, does have a history, and this history needs to be considered in
order to understand why a cartoon that is apparently free of gender stereotypes is
just the latest chapter in the negotiation of the visual representations of women
in the promotion of psychotropic “wonder drugs.” Though pharmaceutical adver-
tisements have appeared in medical journals for over fifty years, this negotiation
is relatively new to magazines such asCosmopolitanandMarie Claire, since the
Food and Drug Administration only relaxed regulations on pharmaceutical adver-
tisements in August, 1997. However, while they have been recently modified for
3Discussion with Eli Lilly Pharmaceutical Sales Specialist, January 14, 2000, University of Michigan
Hospital.
4Friedan, 1963, p. 40.
5Hawkins & Aber, 1988, p. 56.
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mass consumption, popular representations of women in psychotropic medication
advertisements call upon specific themes developed in the pages of psychiatric
journals such asThe American Journal of Psychiatryand Archives of General
Psychiatry, arguably the two most influential American psychiatric journals of the
past half century.
This paper examines the ways women patients, and specifically women pa-
tients whose marital status is used to index their sanity, have been constructed
as abnormal in advertisements designed to promote psychotropic medications to
psychiatrists between the years 1964 and 2001.6 To be sure, a great deal of impor-
tant work has thus far examined the problematic constructions of women in ad-
vertisements for psychoactive medications.7 Social scientists, for example, have
quantified the number of women represented in these advertisements and have
found them to be grossly out of proportion with the number of women who visit
psychiatrists and other health care professionals. Clinicians and health policy ex-
perts, meanwhile, have examined connections between these representations and
the prescribing patterns of physicians.
These advertisements need to be considered as sources of visual history as
well. While I in no way wish to dispute the work of quantitative studies, many of
which I cite below, I believe many of these studies limit the theoretical connec-
tions that can be drawn from pharmaceutical advertisements. This is because the
findings of these studies, by design of course, speak to the problem of pharmaceu-
ticals to women. An analysis of gender-imbalanced prescription rates or resource
utilization, for example, are critiques that focus on the effect of advertisements
upon clinical interactions between doctors and patients, as measured in numbers
of prescriptions or of office visits. However when considered as sources of visual
history, advertisements can be seen to play upon problematic modes of represen-
tation of women, developed over time—and especially so because the images of
pharmaceutical advertisements have historically been loosely monitored by the
U.S. FDA, as opposed to their texts which are tightly regulated for “accuracy.”
Overtly pathologizing the concerns of women as threats to normativity and sta-
bility, the images thereby allow for a consideration of the ways the discourse of
prescription writing is itself situated within larger conversationaboutwomen as
well. The difference between these two approaches is the space between a ques-
tion of if advertisements work, and a theoretical consideration of the reasons why
they work and of the historically and culturally situated structures providing the
necessary conditions for such efficacy.
Such an approach allows me to focus upon two concomitant narratives. On
one hand, I trace the ways in which these advertisements situate their products
6See Levy, 1994, as just one of many articles arguing that these advertisements serve as primary sources
of pharmaceutical “information” for many physicians.
7I focus on medications prescribed for outpatient conditions, such as anxiety and depressive disorders.
I leave out advertisements for “antipsychotics,” which have historically employed different represen-
tational strategies.
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within an era of pharmaceutical innovation described by historian David Healy
as the “golden age of psychopharmacology” (1997, pp. 111–112). Between the
early 1960s and the late 1990s, psychotropic medications helped revolutionize the
diagnosis and treatment of anxiety, depression, and other outpatient mental ill-
nesses in the United States. Through the mid-1950s these conditions were largely
conceptualized within a psychoanalytic paradigm that held rigidly defined het-
eronormative structures of gender at the fore of its conception of the structure
of “normal” personality; and deviations in early relationships between mothers,
fathers, and children as the source of symptoms in later life. To be sure, many
psychiatrists were not psychoanalysts.8 However, psychoanalytic concepts helped
shape the ways in which illnesses were understood and treated throughout the pro-
fession. As an example I develop below, the condition of psychoneurotic anxiety
was described in the profession’s leading diagnostic manuals, theDSM IandDSM
II , and thus defined in many sectors of psychiatry, in explicitly Freudian terms: as
a response to the threat of an “approaching danger” in the “present” triggering a
“painful emotion” not to the present stimulus, but rather to a past fearful state (Di-
agnostic and Statistical Manual of Mental Disorders, I t ed.,1952, p. 31).9 This
emotion was often problematically linked to the fear of a specifically gendered
form of loss, within a conceptual system that all too often defined loss with a
man’s anatomy in mind.
Beginning in the 1960s, however, psychoanalytic treatment models began
to fall out of favor in clinics, residency training programs, and academic depart-
ments throughout the United States. In their stead, psychiatry adopted models of
illness of a more scientific, biological bent. Biological psychiatry defined mental
illness not as the result of gender based conflicts and frustrated drives, but rather
claimed to look beneath the level of culture to the level of organic matter by locat-
ing aberrations and imbalances through research in physiology, neurochemistry,
and genetics. Anxiety was thought of in specifically non-gendered terms: as an
alteration of electrical impulses emitted by the thalamus and the hippocampus,
measured by then state of the art electrophysiological research.10 These aberra-
tions were treated not by psychoanalytic self-exploration, but ever-increasingly
by the administration of psychotropic medications. Psychiatry by many leading
accounts became a more “objectifiable” science (while pharmaceutical companies
became hugely financially successful) as a result (Stone, 1997, p. 239). Many
sources would rightly argue that such changes were to the benefit of psychiatrists,
8In 1958 for example, only one-third of American psychiatrists identified themselves as outpatient-
based psychoanalysts of one sort or another. But the effect of psychoanalysis, in its many different
formulations, spread a much wider circle of influence in the field (Wallerstein, 1991, pp. 421–443).
9When the danger is external this signal is called “fear.” “In Freudian psychoanalysis . . fear,” Alexander
and Selesnick summarized in the influential 1966 workThe History of Psychiatry, “is an alarm
reaction to external danger; anxiety signalizes internal danger” (1966, p. 202).
10These signals would then cause hyperexcitable or “hyperirritable” interneuronal conduction, and
ultimately the clinically observable sensations of sweating, tremor, palpitations, and other “body
discomforts.” See M.D. Altschule’sBody Physiology in Mental and Emotional Disorders(1953).
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who were now better able to assess criteria for illness more reliably; and of per-
sons seeking treatment who were likewise offered the possibility of increasingly
effective forms of palliation.11
However, the advertisements for these same medications also suggest the
ways in which these new scientific cures, and indeed the very notion of objecti-
fiable progress, often could not function free of the culture in which they were
given meaning. Rather, in the space between drug and wonder drug, or between
medication and metaphor, the advertisements can be seen to respond to a social
climate that had a great deal of concern about the role of women in civilization.12
As I explain below, these concerns were neither as static as a hypothalamus nor
as transhistorical as an electrical impulse, but rather closely mirrored oversimpli-
fied notions of the concerns of women—specifically the “threats” to conservative
notions of marriage, family, and social structure represented by women’s political
aspirations—at different points in time. When read with these tensions in mind,
the advertisements reveal ways in which objectifiable psychiatry was complicated
at the very site where visual popular culture commingled with medical science, all
within the pages of leading professional journals. Ironically in the ads, the products
of biological psychiatry were made to participate in the same, regulatory project
as had the discredited psychoanalysis: connecting normal to heteronormal, while
pathologizing threats to “stability” as diseases in need of treatment—only here
these diseases were treated with medications instead of talking cures.
Looking closely at the representational strategies employed in the advertise-
ments ultimately allows me to consider the instability of the biological notion of
anxiety, as it came to be defined in images promoting biological cures. To be sure,
anxiety was made manifest upon the body parts of women, and as the utilization
studies I cite below contend, of many more women than men. But over time, and
through a methodology that I ultimately describe as psychoanalytic, the anxiety of
the patient was meant to become indistinguishable from the anxiety of their doc-
tors, if doctors represent an also oversimplified discourse community concerned
with marriage, fidelity, and other assumed requisites of social order and regen-
eration. Meanwhile illnesses, like dark continents, were depicted as destabilizing
threats to productivity. Slipping freely between inside and outside, information
and intuition, or between an anxiety of the surface and a surface of a projected
depth, advertisements for wonder drugs can thus be seen to promote recuperative
responses, restorative miracle cures, to specific American cultural moments.
Of course most advertisements work precisely through this conflation of trans-
ference and countertransference. Advertisements are not so much full of infor-
mation as they are empty or loose. Successful magazine advertisements, Susan
11Thus “objectifiable” became a catch phrase for psychiatry’s (Feighner, Spitzer) attempts, beginning
in the 1970s, to establish a series of “objectifiable criteria” for the diagnosis of psychiatric conditions.
Historian Michael Stone calls the 1970s “the flourishing of objectifiable science” (p. 239).
12My use of the terms “women” and “men” are meant to imply the oversimplified and ultimately
unstable binary of subject and object constructed in the visual systems of the advertisements.
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Josephson argues inFrom Idolatry to Advertising: Visual Art and Contemporary
Culture, create a broadly understood point of conflict in their viewers—an ellipsis,
an empty space, a feeling of need—which leads to a realization of “anxiety, in the
form of an inadequacy or fault that the product can cure. . .an advertisement can
act best as a reminder; a memory image that viewers can think of when they feel a
desire that needs to be filled” (1996, p. 158). Advertisements thus create anxiety,
and then provide their viewers the relevant information with which to construct
a narrative that resolves the state of tension with an understanding of—hopefully
followed by the consumption of—the brand-named object of promotion.
The difference here, however, is that pharmaceutical advertisements from
medical journals require a slightly more complicated notion of the relational as-
pects of anxiety specifically because a prescription interaction is involved. At the
most basic level these advertisements ask their target audience, primarily physi-
cians, to locate anxiety in someone else. They ask their viewers not to become
aware of an “inadequacy or fault” in themselves, but rather to use their diagnos-
tic powers to ascribe an inadequacy or fault—ever-more by the discovery of a
lack of serotonin than by the recognition of fear of the expression of drives—to
someone they will view at a later point in time. It then follows that the prod-
ucts that “cure” this fault do so not in the doctor, but in the “patient” it ef-
fects. Pharmaceutical advertisements could thus be argued to create anxiety by
the transitive property: while many advertisements seek a direct correlation be-
tween points a and c, if a is the viewer and c is the product, pharmaceutical adver-
tisements must account for, and indeed appeal to, an intermediate point b along
the way.
That pharmaceutical advertisements often successfully negotiate this algebra
is a point I take as a foregone conclusion. While I in no way wish to imply
a causal relationship between image and action, I support the contention made
in Thompson’s “Sexual Bias in Drug Advertisements” that “drug companies, of
course, believe their advertising sells drugs, or they would not be spending millions
of dollars annually on drug advertising.. . . If experience did not show beyond doubt
that a great many physicians are splendidly responsive to current advertising,
new techniques would be devised in short order” (1979, p. 187). Moreover it
is important to note that many women, and many more women than men, visit
physicians seeking treatment for problems that are in many cases successfully
treated with psychotropic medications (Smith, 1985).13 However, pharmaceutical
advertisements have historically (and do currently) profited by amplifying the
frequency of this interaction. They have done so, I argue, by the creation of a
visual language employing historically based tropes of race, class, and gender—
the latter being my primary focus in this paper—to depict patients, and especially
women, as in need of treatment. Blurring the line between marriage and mental
illness, these advertisements asked doctors to conflate the symbolic and the real: to
13See, for example, Hawkins & Aber, 1988; Smith, 1985.
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look at women through predetermined spectator positions, view them as patients,
and treat them as such.
DEPROL, 1964: PSYCHOPHARMACOLOGICAL MOMISM
In many pharmaceutical advertisements in the early 1960s, the married woman
was not only the victim of mental illness, she was the cause of it as well. A 1964
American Journal of Psychiatryadvertisement for the tranquilizer Deprol asked
doctors to make a diagnosis that all-too-well illustrates my point.
By the time the advertisement for Deprol appeared in the pages ofThe Amer-
ican Journal of Psychiatry, the class of “minor tranquilizers” of which Deprol was
a member had only recently become the object of a popular frenzy.14 Approved
by the FDA in April, 1955, the minor tranquilizers soon brought about whatCos-
mopolitanmagazine called “a revolution in the treatment of mental and emotional
illness. . .drugs that promise quick relief for the tense and anxious, without a long,
drawn-out program of psychotherapy” (Cooley, 1956). The drugs were an over-
whelming success: only a few years after their release, one in twenty Americans
was prescribed tranquilizers in a given month (Consumer Reports, 1958, p. 4). Of
these, prescriptions to women outnumbered prescriptions to men by two to one
(Parry, 1968, 1973; Manheimer, 1973).
The long-running Deprol advertisement (Fig. 1 [The images discussed in this
paper appear at <http://www-personal.umich.edu/∼jmetzl/index.html>]) asked its
viewers to enter into a scene likely familiar to many of the readers of theJournal
in the mid-1960s: a clinical interaction between a physician and a middle aged,
white woman. Here it might have seemed these viewers would have had no trouble
locating what Josephson defines as the “anxiety or fault that the product can cure”:
it surely existed upon the woman marked as patient in the foreground of the
image. By presenting a medical encounter at the moment of assessment and before
the treatment has begun, the image invites its viewers to join with the white-
coated doctor in the simple acts of diagnosis and treatment. Even the least astute
professional surely would have noticed that the unmedicated woman to the left of
the doctor appears to demonstrate the conventions of psychoneurotic distress. Her
brow, for example, is markedly furrowed, her gaze nervous and indirect, and her
hand clutches her heart is if she is in the throes of painful emotion.15 A viewer of
this image would hardly have needed to reference theDSM I to ascertain that the
woman suffers from a textbook case of anxiety.
14Deprol was a combination 400 mg of meprobamate with 1 mg of the anticholinergic drug benatyzine
hydrochloride. Although the latter was found to have psychosis-inducing properties in patients with
schizophrenia, the medication was marketed for anxiety depression until well into the 1990s—thus
outliving its more famous Wallace Laboratories progenitor, Miltown.
15This convention was seen in many images. See for example the Bergman-like advertisement for
Trilafon from the December, 1964American Journal of Psychiatry, C4.
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Further, many of the visual markers within the image seem to cede to the power
imbalance between doctor and patient requisite for the diagnosis and treatment
of a clinical interaction in the 1960s to take place. For example the physician’s
considerable authority is vested in his white coat and sanctioned by his framed
license on the wall. From his position behind the desk the physician is clearly
allowed to gaze at the patient with what art historian Tamar Garb calls the “socially
legitimated, historically specific socially and psychically produced look, the non-
innocent look of culture” (1993, p. 220). The woman patient, in the less powerful
position of object, is therefore defined in opposition to the doctor’s medically
legitimated gaze. As such we might well surmise that the advertisement asked its
viewers to think like doctors when viewing the image: to observe the diagnosed but
not-yet treated patient in much the same way that the physician in the image did,
and to come to the conclusion that the diagnosis required treatment with Deprol.
However, the assumed hierarchy of the clinical interaction, and indeed the vi-
sual connection between doctor and patient (within the clinical structure in which
doctors had power and women lacked it), is subtly destabilized by the deploy-
ment of a stereotype: within the meticulously constructed image the woman quite
purposefully holds up her left hand instead of her right and upon the fourth fin-
ger of her fisted hand she wears a large wedding ring.16 Why might the presence
of a wedding ring serve to destabilize authority? And why would such destabi-
lization have been a good marketing strategy when promoting medications to a
largely medical audience? Certainly the image of a woman wearing a wedding ring
was not an unusual cultural trope in the mid-1960s. A wedding ring, and specifi-
cally a wedding ring on a middle-aged woman, might have been thought to imply
normativity, stability, and adherence to the social mores of civilization. Rings,
meanwhile, connoted closure and containment, according toGender Advertise-
ments, Erving Goffman’s classic book examining advertisements of the 1960s and
1970s. Goffman writes “women more than men are pictured using their hands in
advertisements.” That wedding rings feature prominently on these hands, accord-
ing to Goffman, shores up a woman’s place in a cosmology where the coherence
of “the nuclear family as a basic unit of social organization” was primary (1979,
pp. 28, 37). Wedding rings thus serve to locate the women in advertisements, and
the products they represented, within the larger narrative structure in which mar-
riage implied narrative resolution. According to Laura Mulvey (1981, pp. 12–15),
such strategies also pervade western cinema, where marriage at the end of a movie
implies “symbolic social integration” into the patriarchal structure of narrative
(a point Mulvey accesses through the work of Vladimir Propp [1968], who traces
similar tropes in cultural modes of storytelling, arguing that marriage often is an
important convention in the narrative closure of folk tales).
16By “visual connection,” I mean to imply that the visual bond between the patient and doctor was
disrupted by a third point of focus within the image: the ring. The intrusion of the ring thus changed a
standard, psychoanalytic linear narrative (patient-doctor) into a triangular narrative (patient-doctor-
ring).
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The wedding ring in the Deprol advertisement, however, is quite problem-
atically meant to have exactly the opposite narrative effect: rather than being a
symbol of closure and resolution, it is a locus of ambiguity. This is because the
ring opens up the possibility of at least two equally plausible readings—or more
accurately two possible notions of psychopathology—at the same time. First, the
ring ironically implies that the married woman is the source of a mental illness
threatening both the “basic unit of social organization,” the family, and the civi-
lization of which this unit was a part. And second, rather than the married woman
causing the pathology in civilization, civilization could also have been the cause
of the pathology in the married woman.
The former reading seems to be the one supported by the advertisement’s ac-
companying text: “Depression and manifest anxiety,” “oppressive despondency,”
and “self hostility” cause the “aggression and anxiety” that left the patient un-
able to “function” “in home.” Anxiety and depression then left the patient unable
to function as mother and as wife, and unable to fulfill her socially-determined
role. Society, the argument goes, suffers as a result. We need only consider the
obvious manipulation of perspective to understand how such a reading is borne
out by the image: visually foregrounding the un-medicated woman serves both
to phantasmagorically dwarf the suddenly-small doctor, and to not-so-subtly in-
vert the site of anxiety in the advertisement. Goffman describes advertisements in
which the “social weight of power, authority, rank” do not fall along traditional
gender lines: “On the very occasions where women are pictured larger than men,
the men seem almost always to be not only subordinated in social class status, but
also thoroughly consumed as craft-bound servitors” (1979, p. 37). In the Deprol
advertisement, however, the inversion of the status relationship moves the anxiety
from the patient to the doctor, thereby complicating Goffman’s notion of servitude.
The licensed, white-coated physician is clearly marked as the bearer of authority,
rank, and office, yet his authority is visually subverted by the untreated patient.
The woman’s size, and her potential for what the advertisement describes a her
“aggression” and “hostility,” present her as a threat not only to the doctor, but to
the requisite structure of the medical interaction.
Presenting an oversized, married woman as a threat to the authority of men
is a message that would likely have carried a great deal of cultural valence in
the late 1950s and early 1960s. The previous decade saw the sociopathology of
“Momism,” a term coined by Philip Wylie in the hugely successful bookGenera-
tion of Vipers(1942, 1955), enter into common parlance. Momism lay the blame
for a vast array of psychological and social problems squarely on a single group
of culprits, “American mothers.”Generation of Vipers, and Momism specifically,
tapped into overwhelming popular sentiment in the postwar period that blamed
pathologically-empowered women for the emasculation of men. Wylie attacked the
domineering American mother as a “domestic powerhouse. . .who spends several
hundred dollars a year on permanents and transformations, pomades, cleansers,
rouges, lipsticks and the like.” She “ruled” over her husband and children with
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“sharp heels and a hard backhand.” Mothers, Wylie argued, had assumed “domes-
tic authority” through “aggression” and “oppression”—the very same terms used
in the Deprol advertisement. The result was a dynamic that “robbed men of their
virility.” As such he blamed mothers for an incredible array of maladies in men,
from thumb sucking to premature ejaculation. And since Wylie called upon Freud
to readily conflate the ills of the individual with those of civilization (“the philos-
ophy of the state is only a magnification of the philosophy of the person”), he also
blamed mothers for dismembering the country as well, creating an apathetic, “sick
society” (pp. 1, 184, 201, 298).17
Momism is important for the purposes of this paper because its visual aesthetic
was defined by large, intimidating women, and by resultantly shrunken men. Such
representations were seen in images ranging from the cartoons of James Thurbur,
to representations on the cover ofLookmagazine (March, 1959), to the Osborne
cartoon from Eve Merriam’s 1958 satire inThe Nation(November 8, 1958, p. 332)
entitled “The Matriarchal Myth, or The Case of the Vanishing Male.”18 In each
case the constructed threat of woman—much like the inverted power relationship
between a large, well-manicured patient and a relatively shrunken doctor—was
presented as a destabilizing threat to the structure of society.
In Feminism and Its Discontents(1998), Mari Jo Buhle grounds the popular
appeal of Momism in the resonance between popular perception and psycho-
analysis. Buhle argues that Momism, and Wylie’s self-described “psychoanalytic
methods,” rose from Freudian origins and “its ability to tap into psychoanalysis
as a popular discourse” in the 1950s. The result was an attack on motherhood that
both mirrored and helped shape popular sentiment. Buhle compellingly argues that
the discourse of Momism suffused psychoanalysis as well. As just one of many
examples, Buhle asserts that American ego psychologists “sought out not mother-
hood’s beneficent, but malignant potential. With the assistance of popularists like
Wylie, psychoanalysis transformed mothers into the principle agents of children’s
disorders, and the maladies that plagued the nation” (pp. 127–131).
And yet psychoanalysis failed to dictate the politics of the consciousness of
the self in American psychiatry in the latter half of the twentieth century. Rather,
American psychoanalysis suffered what historian Nathan Hale (1995, p. 300) de-
scribes as a “rapid decline in the field,” replaced in clinics and in training programs
by a biological model envisioning mental illness as result of biologically, and of-
ten chemically influenced disorders of brain chemistry treated by Deprol and other
medications. Over the coming years biological explanations for illness and health
17The book was an overwhelming success. Revised for a second printing in the years preceding the
Deprol advertisement, the book sold over 180,000 copies between 1956 and 1966.
18“The myth of the Big Momma is on the upswing. When Philip Wylie crusaded some years back for
misogyny, a fair-sized opposition went into action. But now everybody’s in his corner. It would seem
that Wylie’s rantings weren’t wrong: he was simply a bit too prematurely anti-Mom. The impact of
the Big, Bad, Bold Momma has become part of the American way of life . . and as Big Momma thus
brazenly ascends the scale of things, so Big Daddy has come down” (Merriam, 1958, 332).
P1: FLT
Journal of Medical Humanities [jmh] PH162-jomh-454188 November 23, 2002 16:29 Style file version June 4th, 2002
Selling Sanity Through Gender 89
would become the foundation for the ways psychiatry thought of selves, while
prescriptions, and not analysts couches, framed many of the interactions between
doctors and patients. As a 1964 Deprol advertisement suggests, the new “science
of the mind” was unable to transcend either Freud’s mom or Wylie’s Momism.19
And, at the very historical moment when medications became widely accepted
in outpatient treatment—and the moment that the science that would ultimately
come to replace psychoanalysis as a diagnostic and treatment model in American
psychiatry was just being defined in the profession—we see a method of appeal
based in the assumption that an uncontrolled, married woman is as much of a threat
to the white-coated biologist as she had been to the psychoanalyst. Implicitly, the
threat this woman presents is constructed as her direct confrontation of male power
and privilege.
This then leads to the second implication suggested by the wedding ring in
the Deprol advertisement, and in many other advertisements of the mid-1960s
connecting visual markers of marriage with the symptoms of mental illness: rather
than the married woman causing the pathology in civilization, civilization could
also have been the cause of the pathology in the married woman. Marriage, in
other words, might not have only been an institution that empowered women to
become domestic superwomen; it might also have been an arrangement that drove
middle aged, white women to visit psychiatrists. In this case the ring could also
have implied a mother’s dissatisfaction, and even despair with the structure of mar-
riage, and by extension with the structure of society. Such a reading also connects
to a larger historical correlate. At the same moment Momism enjoyed its final,
senescent days in the sun, many mothers began to voice their unhappiness with an
American culture that was, to slightly refigure the language of the advertisement,
despondently oppressive.
For example, Betty Friedan’sThe Feminine Mystiquewas published in the
same year the Deprol advertisement first appeared. Often described as the turning
point in the second wave of feminism, the strength of Friedan’s argument lay in
tracing the “shift” in the female image from the “Madonna/whore” binary that tra-
ditionally characterized “men’s representations of women,” to the “split between
the feminine woman, whose goodness includes the desires of the flesh; and the ca-
reer woman, whose evil includes every desire of the separate self”(Friedan, 1963, p.
40). Such stereotypes were intimately connected with psychotherapy. The “bright,
well educated career woman” was the woman as so frustrated, so “masculinized
by her career that her castrated, passive, impotent husband is indifferent to her
sexually” that she seeks “help from a psychiatrist” (pp. 51–52).20 That Friedan’s
19This theme appeared in many other advertisements. See for instance Librium, 1971,Archives of
General Psychiatry, 24(4), front cover.
20Friedan attacked Freudian psychoanalysis as “an all embracing American ideology” whose patriarchal
structure prohibited women into questioning long standing prejudice into “dogma.” In April, 1963
the book joined the best seller list. By 1964, it had become the best selling paperback in the country.
Publisher’s Weekly(January 18, 1965, pp. 68, 72).
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book both reflected and gave voice to the discontent felt by many of the housewives
it described is a point that hardly needs to be argued. Susan Douglas writes, “The
real tip-off that many of our mothers hated their assigned positions, weren’t sure
whether to hate themselves or the men around them, and were tired of straddling
the untenable contradictions in their lives was the eagerness with which thousands
of them ran out to buyThe Feminine Mystique” (1994, p.125).
Advertisements, like Rorschach tests, are texts that ultimately profit by am-
biguity, and pharmaceutical ads of the 1960s are no different. It is impossible to
discern which reading of the ring was intended—this is, of course, the point—and
even if we could it would tell us little about its role in the advertisement’s recep-
tion. My point in citing works such asThe Feminine Mystiqueor A Generation of
Vipersis not meant to imply that the makers of drug ads read, or were effected by,
these works. I do believe, however, that in the ambiguity of a symbol, pharmaceu-
tical advertisements found an ironic means of connecting the tensions inherent in
Wylie’s and Friedan’s books, and more importantly in the social movements they
represented. In the space between the decade before and the decade to come, or
between the threatening mom of Momism and the protesting mom of feminism, the
wedding ring translated both the concerns of women and of men, of patients and of
doctors, into the language of illness (itself equivocal to the point of inobjectivity)
and its brand named cure.
VALIUM, 1970S: JAN’S FEMINISM
How much did the conventions of pharmaceutical representation change by
the time America’s next wonder drug arrived? It seems only as much as the women’s
movement itself had changed. Valium has long been called a “mother’s little helper”
as a result of its massive over-prescription to middle class women in the 1970s. But
as revealed in the subtle difference between two seemingly similar advertisements
in theAmerican Journal of Psychiatry, Valium might have been a drug intended
for daughters as well.
If the 1950s and the early 1960s were an era in which mainstream popular
culture worried about Mom, then perhaps the late 1960s and early 1970s was a
time to worry about the next generation of women. In the late 1960s the women’s
liberation movement burst onto the national stage. “Many of the new feminists
are surprisingly violent in mood,”Timemagazine’s November, 1969 article “The
New Feminists: Revolt Against Sexism” explained, complete with photo expos´s
of “angry young women” who “hated men” and “learned karate,” and descrip-
tions of the legions of women who “burn their brassieres” (pp. 53–56). In March,
1970,Newsweek’s “Special Report: Women in Revolt” explained that “women’s
lib groups have multiplied like freaked-out amoebas. . . spreading a hostility that
is gravely infectious” (p. 70). The references described a diverse women’s move-
ment that fundamentally questioned patriarchal institutions such as marriage, and
P1: FLT
Journal of Medical Humanities [jmh] PH162-jomh-454188 November 23, 2002 16:29 Style file version June 4th, 2002
Selling Sanity Through Gender 91
the very “male-female role system” (Koedt, 1971) they implied. Kate Millett was
featured on the cover ofTimein August, 1970, in an article condemning her argu-
ment inSexual Politicsthat women’s oppression originated in men’s “sexual power
over women,” and took on an institutional form through the political economy of
patriarchy (p. 1). Ti-Grace Atkinson explained to a national television audience
that “Marriage means rape” (Douglas, 1994, p. 175). Jill Johnson upped the ante
by claiming “a true political revolution would not occur” until “all women are les-
bians” (1973, p. 166). Psychoanalysis, and Freud specifically, became a target of
attack in the ensuing debates about biology as destiny, and biology as determinism.
“Freud,” Millet wrote, “is the strongest counterrevolutionary force in the ideology
of sexual politics” (1970, p. 23).
Yet far from the national glare, a biology claiming to be beneath anatomy
or destiny grew in stature in the field of psychiatry. The mid to late 1960s and
early 1970s were a time of remarkable progress in understanding the links be-
tween neurochemistry and behavior. Split-brain research, evoked potentials, and
the discovery of neural pathways and neurotransmitters moved psychiatry farther
away from the role of gender and culture to identity formation—instead focusing
beneath these constructs to the level of the biological substrate (Ayd, 1984, p. 125).
Brains and pathways and peptides, in other words, were described as largely the
same in women and men, in wives and in husbands.
Riding the crest of this new science were the next miracle treatments in the
fight against the anxiety of everyday life, the benzodiazepines, of which Valium
was the most famous public ambassador. Approved by the FDA in 1964, Valium
was shown in 1967 to “reduce the activity of serotonin neurons and reduce the
activity of norepinephrine neurons” (Corrodi, 1967, p. 363).21 What followed was
what theNew York Times Magazinewould aptly describe as “Valiumania” (Cant,
1976). In 1969 Valium became the most widely prescribed medication in the United
States, on its way to becoming the single most successful drug in pharmaceutical
history. By the early 1970s one in ten Americans was taking Valium for tension
and nervousness. According to many credible studies, up to 70.5% of regular users
were women (Chambers, 1972).
The tensions of science and of society once again met in a mainstream pro-
fessional journal when a series of similar advertisements appeared inThe Archives
of General Psychiatryin the summer of 1970. Valium’s marketers did not take
any chances with the ambiguity of a ring to connect mainstream anxieties about
the role of women with the selling of psychopharmacology. Rather, the connection
was made explicitly on the page. Here the narrative defined by Josephson, in which
advertisements create points of tension, and then provide their viewers the rele-
vant information with which to construct a therapeutic temporality that resolves
the state of tension with a brand-named product, unfolds in a narrative trajectory
from top to bottom, left to right, and past to present.
21These actions would later be attributed to the disinhibition of the neurotransmitter GABA.
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The first of the two-page advertisements (Fig. 2) appeared inside the front
cover of the journal in April, 1970.22 A series of framed pictures, arranged chrono-
logically, construct a visual narrative of a woman named Jan. The advertisement
invites its viewers to “read” the story of Jan’s fifteen year history of unsuccessful
heterosexual relationships after her happy childhood playing tennis with her father
(top left). But neither Tom (top, middle), nor the James Dean-like Joey (top, right),
nor buff Charlie (middle, right), nor drunken, groping Bunny (bottom, left) mea-
sure up to Dad (who reappears in the bottom, middle image). “Jan never found a
man to measure up to her father,” the text explains. The narrative’s final photograph
(bottom, right) shows Jan alone on a ship, looking forlorn while standing near a
life preserver.
A simple comparison reveals a glaring difference between Deprol and Valium:
in the space of six years, the single woman replaces the married woman as the
marker of pathology and abnormality. While the Deprol presented marriage as
the source of anxiety, Valium shifts the medical gaze to a woman’s lack of a man
rather than her control of one. Here the mental illness from which Jan suffers in
the Valium advertisement—her inability to find the right man—is unequivocally
presented not merely as the result of illness, but as the illness itself. As the text
reveals, she is “35 and Single,” and unable to find a man. Drug advertisements,
it seems, had negotiated the path between Momism and Daughterism, and had
emerged with a new product in the fight for restoration.
We might infer however that the Valium advertisement’s message presented
some problems even within the world of pharmaceutical advertising. In pharma-
ceutical advertisements in general, social and cultural tensions are used to broaden
existing definitions of disease, thus expanding the pool of potential consumers. The
more an advertisement can persuade a physician-viewer to think of quotidian as-
sumptions as pathological, the more the product-in-question is prescribed, bought
and sold. In the Valium advertisement as it appeared in the April, 1970Archives,
however, a line seems to have been crossed for one simple reason: there was no
disease except for a social disease. The mental illness appeared entirely under era-
sure, and was completely effaced by gender inflected social and cultural tensions.
While advertising agencies are highly secretive about the processes involved in
image production, we need only look at the advertisement as it re-appeared two
months later to wage an educated guess about intent.
When the advertisement re-appeared inside the front cover of the June, 1970
Archives of General Psychiatry(Fig. 3), the word “psychoneurotic” suddenly ac-
companied the word “single” in the heading.23 One might well surmise that the
addition of psychoneurotic was meant to imply that a patient’s visit to the psychi-
atrist might have had at least a vague connection with psychopathology and that
Jan’s failure to adhere to social mores of coupling might not have been her only
22Archives of General Psychiatry, 22(4), 1970.
23Archives of General Psychiatry, 22(6), 1970.
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reason for seeking treatment. Importantly though, nothing else in the advertise-
ment is changed whatsoever. The flow of images, from dad to desperation, remains
entirely intact. As such the pictures tell the true story: not merely that the diseased
patient was the single patient, but that single in this caseis the disease—a disease
that would be cured, thinking of the Proppian narrative, were the patient to get
married.
However, beneath this troubling shift in nosology and the changing conven-
tions of representation, the Deprol advertisement and the Valium advertisement
are more similar that it may initially appear. Three important points of connection
link the construction of the two advertisements. The first of these similarities func-
tions at the level of the sales pitch, the address made by the image to the viewer.
Like the Deprol advertisement, the Valium advertisement asks its viewers to enter
into a narrative in medias res, at a moment immediately prior to the initiation of
treatment. In both images the moment of encounter begins when the “illness” has
reached its most symptomatic moment—the moment of presentation to the physi-
cian. Jan, like the woman in the Deprol advertisement, comes to the physician’s
office when her symptoms cross the line from despair to disease. Here, true to
Josephson’s definition, these viewers are asked to think with the authority of doc-
tors: to recognize the presence of psychopathology, and to construct a diagnostic
narrative which leads to the conclusion that the object of their gaze required a
specific brand of medication.
Second, both advertisements use not entirely subtle cues to bolster the view-
ers’ sense of their own authority, if authority means an identification with the name
of the father. In the Deprol image this was accomplished by the fatherly figure of
the physician, along with whom viewers were invited to gaze at the motherly figure
of the patient. In the more subtle Valium ad the spectator is invited quite literally
to be the father, or the man who measures up with the father. The flow of images
tell the story of Jan’s search for a man who could “measure up to her father,” a
search that seems to have ended in despair. The “final” photograph of Jan alone
near the guard rail raises the possibility that her search ended with a plunge into
the abyss. However, the present tense syntax of the text reveals that Jan lived to
visit the psychiatrist—“Now she realizes she’s in a losing pattern—and that she
may never marry”—a psychiatrist overtly assumed to be male.24 The thinly veiled
message borders on a breech of the Hippocratic Oath: the psychiatrist is asked to
be the next man in the narrative, and the man who might finally make Jan happy.
The psychiatrist is thus invited to stand next to Jan in the photo, and to provide a
welcome sense of closure. Lest a viewer miss this message, a glaring empty space,
an ellipsis just large enough for one last photograph, is provided to the immediate
right of the now-penultimate image of Jan on the ship.
Third and finally, the gendered form of mental illness within both images,
whether single or married, functions in remarkably similar ways. In the Deprol
24A point known historically from Deprol, if not textually from the photographs.
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advertisement the symptoms of the married woman were depicted as an emascu-
lating threat to the power of the physician. The image suggested that the woman’s
anxiety, and the possibility that her anxiety might be the result of dissatisfaction
with the social order, were labeled as a component of “the disease.” In the Valium
advertisement the symptoms seem to be markedly different. Here too, however, the
threat of illness is constructed as the threat of a reading outside of a heternormative
economy: just as the ring raised the possibility of discontent with the system, so
too does the single woman present a threat to the white coated, nuclear “way things
should be.” The single woman, and specifically a single woman in the early 1970s,
raises the possibility of a constellation of alternative symptoms and alternative
readings. Maybe Jan prefers a union with another woman. Perhaps she wishes to
live alone. Perhaps she needs a man like a fish needs a bicycle, or burns her bra, or
reads Kate Millett, or is a vector for a gravely infectious social pathology. Each of
these readings raise the possibility of a life beyond, or a life without, the doctor’s
control. Each broach the prospect that the doctor’s power—the power to bring a
patient back into the fold—might not be all that it seems. Each, under the broad
rubric of 35 and single, is marked as pathology. In other words, symptoms carry
the potential of undermining the authority of the doctor and destabilizing the basic
structure of the social order he came to represent. This then turns the traditional
notion of a symptom on its head, if a symptom means the complaint suffered by
the patient. To be sure the symptoms constructed in the ads might appear similar to
ones that affect patients. But within the visual systems created in advertisements
over time, and viewed by the prescriber rather than by the recipient of medications,
these symptoms threaten the doctor much more.
PROZAC, 1998: RESOLUTION
Almost twenty five years and a cultural revolution later Prozac became Amer-
ica’s next psychotropic wonder drug. Prozac, and its class of SSRI antidepressants,
were found to selectively inhibit the brain’s uptake of serotonin. “We believe,” sci-
entist David Wong et al. wrote in the journalLife Sciencesin 1974, “the discovery
of specific inhibitors of 5HT reuptake like II0I40 will help in elucidating the func-
tion of 5HT in the brain and the importance of reuptake as an activating mechanism
in 5HT neurotransmission” (p. 471). The result was a medication widely believed
to resolve the symptoms of depression and anxiety without the risk of addiction, or
the danger of overdose. Released in December, 1987, Prozac became the number
one drug prescribed by psychiatrists by 1990. “Susan A. has spent most of her
adult life fighting with people—her parents, her husband,”Newsweek’s March,
1990 article “The Promise of Prozac” (pp. 38-41) explained. “But within a month
(after taking Prozac) Susan had given up psychotherapy in favor of school. . . ‘I
feel 1,000%’ she said in a handwritten note ‘. . . I actually like Mom & Dad now,
and my marriage is five times better.’” “Prozac. . . is much more than a fad,”Time
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explained in a suspiciously similar 1993 article, “The Personality Pill.” “It is a
medical breakthrough that has brought relief to individuals such as ‘Susan,’ a self
described workaholic who becomes irritable around the time of her periods and
once threw her wedding ring at her husband. Now the edges of her personality
have been planed off a bit” (p. 53). By 1994, Prozac was the number two selling
drug in the United States (Wall Street Journal, March 31, 1994, p. B1).
It would stand to reason that a great deal had changed in the politics of
representation in the more than two and a half decades between the appearance of
Jan and the appearance of the Prozac advertisement. Many surveys would present
evidence that the women’s movement fundamentally changed conditions for many
women in the United States. A 1989Timemagazine poll reported that 77 percent
of women believed the women’s movement had made life better, 94 percent said
it had helped women become more independent, and 82 percent reported it was
“still improving” the lives of women (Wallis, 1989, p.84) These changes were felt
in medicine as well, where the numbers of women physicians, and the number of
women physicians who read psychiatric journals, steadily increased. Finally, the
portrayal of women in pharmaceutical advertisements had come under scrutiny, in
large part due to feminist protests emerging from the social sciences in the 1980s
(Courtney & Whipple, 1983; Hawkins & Aber, 1988), resulting in what were
widely believed to be substantive changes in the ways women were portrayed in
pharmaceutical advertisements in the 1990s.
One could certainly argue that much of this change was apparent in 1997,
when an advertisement for the SSRI antidepressant Prozac touting the medication’s
success in promoting “restful nights and productive days” appeared simultaneously
on the back covers ofThe American Journal of Psychiatry, Psychiatric Times, and
then reappeared continually for the course of two and a half years (until it was
replaced by a basketball in 1999).25 For example, the woman in the advertisement
is clearly depicted as a generative, working member of society. In her “productive
days” she is seen to hold fruitful employment. She then sleeps soundly in her
“restful nights.” There seem to be no overt signs of Momism, men, or misogyny in
the picture. Neither is there a threatened physician, nor a bra-burning militant. The
woman appears to be anything but the passive stereotype of the feminine mystique.
Prozac, to quote the popular slogan, means progress in an exceedingly 90s sense of
the word: it restores productivity without a hint of dependence. Such productivity
seems to illustrate what Peter Kramer inL stening to Prozacalls “a normal or near
normal condition called hyperthymia. . . . Hyperthymics are optimistic, decisive,
quick of thought, charismatic, energetic, and confident. Hyperthymia can be an
asset in business” (1994, p.16).
However, the advertisement’s tacit claims of progress begin to unravel when
considered within the representational continuum, developed over forty years,
25The ad appeared monthly in these journals, often occupying the back cover. Readers are asked to
view the image in such issues as theAmerican Journal of Psychiatry, Volume 155, Number 12, 1998,
p. A7; or in enlarged form inPsychiatric News, Volume XXXIII, Number 24, 1998, back cover.
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linking women, marriage, and the marketing of pharmaceuticals. With visual his-
tory in mind, we begin to see the ways in which the Prozac advertisement represents
a specific response to, rather than a departure from, this evolution. Three intercon-
necting representational strategies serve to illustrate the ways in which the Prozac
advertisement is in conversation with its history. First, the advertisement enters the
clinical narrative at a different starting point than did the advertisements for Deprol
or Valium. The Prozac image asks it viewers to enter the scene at a moment after
the treatment has already taken place and after the visit to the doctor has already
occurred, thereby asking its viewers to construct narratives of treatment rather than
of illness, or of follow up rather than of diagnosis. The woman appears free of the
symptoms seen in previous images. Her forehead, for example, is airbrushed free
of the furrows painted upon the brow of the woman in the Deprol advertisement.
She certainly does not appear to be standing by the guardrails contemplating sui-
cide, as did Jan in the Valium image. The moment of encounter is one in which
the tension of illness has dissipated, the work already done. The woman, in other
words, looks normal.
Second, the Prozac image, like the Valium image, presents an ellipsis next
to a lone woman. To the right of the sleeping woman (the same dominant side
occupied by the physician in the 60s, and by a gap in a picture book in the 70s)26 is
a suggested space where a partner might lie, covered over by the other image and by
text. Here, however, the image depends upon a different interpretive strategy, since
every indication suggests that the space is occupied: the hint of a second pillow,
accompanied by draped bedsheets to the right of the “restful” woman implies that
she has a partner sleeping next to her. Third and finally, the woman in the Prozac
image prominently displays the fingers of her left hand both at work and in bed;
and upon the fourth finger in each scene she wears a shining, gold wedding ring.
Indeed the wedding ring is held at the visual focal point of both images of the
woman in the advertisement. By its appearance both at work and in bed, the ring
functions as a point of connection between both images. Moreover in bed the ring
appears consciously, almost un-naturally placed, as if to highlight its presence.
Is this the same wedding ring as the one worn by the woman in the Deprol im-
age? Certainly it appears to be the same thin, gold band worn on the hand of a middle
aged, white woman. However, within the specific resonance between these three
points—a different point of narrative entry, combined with a not-entirely empty
space and the familiar symbol of a ring—we begin to realize an important change
in the system of signification. The wedding ring in the Prozac advertisement, and
more to the point, the ring depicted in bed on the hand of an admittedly “cured”
woman, functions visually in exactly the opposite manner as it had in the Deprol
image. The presence of a wedding ring upon the hand of a symptom-free woman
who is likely not sleeping alone subtly implies that unlike her long-suffering pre-
decessors, the Prozac woman has taken her place in the social order. Here the ring
26As opposed to the weaker, sinister side upon which wedding rings are worn in Western culture.
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functions not as a marker of a Momist threat, as it had in the Deprol image, but as a
marker of restoration; or as a symbol of enclosure and containment rather than of
ambiguity. To be sure, the suggestion of a partner, combined with the absence of
distress, suggests that the mental illness from which the woman no longer suffers
is the very same ailment borne out of the feminist movement in the 1970s. And
yet what was once a threat—a symptom—has become docile and domesticated,
both in work and in love. The ring indicates that the productive, 90s woman is
essentially less of a threat than were her disgruntled feminist predecessors. The
ring in other words implies that the 1990s Prozac woman is neither Jan, nor is
she the woman from the Deprol image, for the same, simple reason that she is
symptom-free: because unlike the woman in the Deprol image, and unlike Jan, the
woman in the Prozac advertisement had taken psychotropic medication.
This distinction holds true in numerous advertisements for psychotropic med-
ications throughout the late 1990s—advertisement which often reappear for years
on end.27 Here a wedding ring—and specifically a wedding ring on the finger of a
middle aged, middle classed, white woman—works to identify the cured patient in
representations where it might be otherwise unclear. Together these images suggest
a fundamental shift in the system of signification: the ring, almost a quarter-century
later, marks a woman not as mentally ill, but as medicated.
CONCLUSION: ANXIETY
Why is the changing trope of marriage in the pages of psychiatric journals
a cause for concern? Surely many popular advertisements show women wearing
wedding rings very similar to those rings worn by a great number of married
persons in real life. Moreover, I in no way doubt the sincerity of the message
that women successfully treated with psychotropic medication are often able to
live happy, productive lives; lives that include marriage, and companionship, and
everything else that is ostensibly threatened by illness.
However, the shift in the meaning of a wedding ring, and its connection to
psychotropic medication, raises troubling implications in the context of a discus-
sion of advertisements directed not at consumers, but at doctors. As I describe at
various points in this paper, a great many changes have taken place in the profes-
sion of American psychiatry in the time span separating the Deprol and Prozac
advertisements. One could argue that the difference between an image depicting
a verbally interactive relationship between a doctor and a patient and an image
27See the Effoxor campaign of 1998, “I got my marriage back,” as the most egregious example. See also
the “Prozac Promise” series of 1997, and the Luvox mother and child series of 1997. Meanwhile other
high-profile images spell out the historically developed trope even more graphically, as suggested by
the “Effexor: I Got My Mommy Back” campaign, 1997–1999, in which an Effexor-treated Mommy
returns to the heteronormative fold. All campaigns unfold in both theAm rican Journal of Psychiatry
and inArchives of General Psychiatry. Although I do not address television ads in this paper, this
convention made its way to Buspar advertisements in 1999–2000.
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asking a doctor to view a preexisting relationship between a patient and a med-
ication correlated with changes in clinical practice. Over this period a system of
therapeusis based in the nuances of the interpersonal interaction fell out of favor
across the wide spectrum of the field, to be replaced by a treatment system in which
the relationship between doctor and patient was thought secondary to each party’s
relationship to medication. A doctor’s role increasingly involved selecting medi-
cations, while a patient’s role involved ingesting them. This difference in valuation
helped bring about markedly shorter office visits and care givers often trained in
the subtleties of pharmacokinetics at the expense of the kinetics of intersubjective
communication. Many historians of medicine, and certainly many practitioners,
contend that these changes were to the great benefit of the profession. Psychiatry,
the argument goes, became more precise, more practical, and even more gender-
blind when the object of its gaze shifted beneath the level of maternal based conflict
to the level of serotonin. Edward Shorter’s 1997A History of Psychiatry, as just
one example, relies heavily upon medical and psychiatric literature to claim,
Between the 1950s and the 1990s, a revolution took place in psychiatry. Old verities about
unconscious conflicts as the cause of mental illness were pitched out and the spotlight
of research turned on the brain itself. Psychoanalysis became, like Marxism, one of the
dinosaur ideologies of the nineteenth century. Today it is clear that when people experience
a major mental illness, genetics and brain biology have as much to do with their problems
as do stress and their early childhood experiences. And even in the quotidian anxieties and
mild depressions that are the lot of humankind, medications can now lift the symptoms,
replacing hours of aimless chat. If there is one central, intellectual reality at the end of the
twentieth century, it is that the biological approach to psychiatry—treating mental illness as
a genetically influenced disorder of brain chemistry—has been a smashing success. Freud’s
ideas, which have dominated the history of psychiatry for the past half century, are now
vanishing like the last snows of winter. (1984, p. 539)
To be sure, the psychoanalysis to which Shorter refers was historically a prob-
lematic and possibly outdated system of care. It was at times as exclusive as a coun-
try club and as elitist as a black tie dinner. It had a hard time answering questions of
outcome. And it often had serious conceptual and practical problems with gender.
And yet psychoanalysis also gave language to the ways in which interactions—
both contrived clinical interactions and the life interactions they replicated—could
not exist free of the tensions of gender and power. The perceptions of the patient, in
other words, were only defined in conversation with the perceptions of the doctor,
while medical “knowledge” was only defined in inter-relationship with its larger
context. For every transference there was a subsequent countertransference, for ev-
ery manifestation a prior, if not entirely latent, threat. Nothing within this system,
not even the most seemingly denotative of exchanges, could be understood free
of an often-erotic matrix of signification and exchange. A cigar, in other words,
was never really just a cigar. Biological psychiatry, meanwhile, was a more precise
endeavor. It often took at face value the nuances of intrapsychic process, and just
as often eschewed (or blanched at) the embarrassment of penises and absences,
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of lust and of lack. Description was followed by prescription, and prescription
by compliance, and often in fifteen minutes or less. No doubt the system of care
became more efficient, and certainly more objectifiable, as a result.
In his warm embrace of the brain, however, Shorter overlooks the point that
the advertisements make clear: medication, and the rise to power of medication,
did not entirely replace psychoanalysis, nor did the chemical imbalance replace
the concerns of the talking cure. Instead, medication was effused with the very dis-
placement and the fear of loss that the profession of psychiatry was in the process
of eliminating from its vernacular. Were Shorter to at least consider the possibility
that biology might have accrued and enacted remnant components of psychoanal-
ysis before that field melted (after all, the last snows of winter give rise to the first
flowers of spring), he would surely have realized that even the most objectifiable
of symbols are never defined in a vacuum. Rather, in the progression of adver-
tisements, we see the ways in which symbols often could not function free of the
culture in which they were given prescriptive valence, and became imbued with
the same anxieties, the same gender politics, and even the same sexual tensions at
play in the larger structure of which psychoanalysis and biology both were (and
are) a part.
How then did pharmaceutical advertisements promote enormously profitable
brand named medications for outpatient illnesses between the years 1964 and
1999? They certainly did so, as Josephson might have argued, by the construction
of “anxiety” in women, if anxiety meant accessing the clinical narrative of medicine
in order to emulate a condition in need of a diagnosis and a cure. And they likely
did so by conflating a symbol of the normativization of marriage (and possibly
even a symbol of the normativization of feminism) into a symbol that served to
normativize mental illness, in the process ever-expanding the indications for the
products in question. What once was fringe became mainstream as if by a corporate,
commodified act of destigmatization.
But as the shifting trope of marriage reveals, the advertisements also sought to
work by translating the developing language of medication into a broader, grossly
oversimplified discussion of the anxiety of men: men as doctors, and men as the
larger category these doctors were constructed to represent within the time-honored
visual systems of advertisements. In this sense anxiety was not merely presented as
the problem described by a patient (either Jan or Susan) who may have felt unhappy
in her marriage, or unhappy with her inability to find marriage, or unhappy with
the realization that she might never rise above a middle management job. Anxiety
was also constructed as the sense of inquietude in the doctor, made uneasy by the
threat these symptoms came to represent. With psychoanalytic paradigms firmly
at the fore, the advertisements asked their viewers look as men, and look at their
patients as women.
The threat implied in the images is, by design, a matter of interpretation.
Possibly the threat is of a professional nature, if considered within the context
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of the shifting power structure of the clinical interaction. Here symptoms once
treated solely by the psychoanalytic power inherent within the man were ever-
increasingly reliant upon the prosthetic power of the medication. At the same time,
the images also asked their viewers to think of women’s symptoms as representing
threats that destabilized the very civilization—thinking of the connection between
Freud’s and Wylie’s use of the term—within which the clinical interaction took
place. In the most traditionally psychoanalytic sense, in other words, the anxiety
realized by looking at a woman implied a direct threat to the well-being of men, as
if unwanted intruders returning from the repressed. Growing women, as the Deprol
image revealed, meant shrinking doctors and shrinking men, as if by LeChatlier’s
principle. And militant, unattached women, as Kate Millet and Ti-Grace Atkinson
argued and as Jan made painfully clear, raised the possibility of new arrangements,
new normatives, and new social orders.
Of course images of women constructed through the anxieties of men is
hardly a novel narrative structure, either in medical advertisements or in medicine.
The pathologization of the single woman, or the unmarried woman, or the lesbian
extends through the history of psychiatry and many years beyond (see, for example,
hysteria and its treatments). In this particular context, however, the stereotype of
male anxiety was given a means of discharge by images specifically constructed to
enhance the dispensing of psychopharmacology. Between an image of a married,
symptomatic woman in an office, and of a married, symptom-free woman in bed
three decades later, lay the implicit assumption that a crisis has been resolved,
and order restored. In this visual system, however, the symbol of the resolution of
anxiety and the assertion of control—the wedding ring—was connected not only to
marriage, but to prescription. The images, in other words, conveyed the message
that a man’s anxiety was not the passive, helpless state it may have been when
it was described by Freud. Rather it was a state that could now be assuaged by
resolving a crisis in someone else. Objectifiable, in this equation, bordered closely
on objectification. The woman who threatened the doctor in 1964 slept with Prozac
in 1997, and the empty space vacated by the shrinking Deprol doctor was filled,
thirty four years later, by the growth of the symbol. And within advertisements
in mainstream medical journals between the years 1964 and 1998, the very same
period in which these same psychotropic drugs in question were prescribed to
women by rates up to four to one compared to men, this symbol was constructed
as the symbol of psychotropic medication.
Again, I am arguing neither for cause and effect nor for stimulus and response.
Moreover, advertisements were far from the only texts involved in constructing
the meaning of medication—a point I have implied by referencing just a few of the
numerous other types of texts where related discussions concomitantly took place.
Advertisements did however illustrate, and often amplify, tensions or fears already
existing within the culture of their viewership. As such, I believe that in certain
images assumed to be viewed by doctors, there functioned a visual language that
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tried (and tries) to make it easier for men to write prescriptions for psychotropic
drugs to women. Moreover this language spoke to an anxiety not entirely within the
presenting woman patient, but within the doctor as well, who was cued in, as it were,
before the patient ever entered his office. When viewed over time, the images of
psychotropic advertisements thus seem to promote the message that viewing, male
doctors could react to various forms of anxiety, whether job related, psychological,
or otherwise, by the act of writing a prescription. Prescription writing, in this
system of not entirely chemical imbalance and rebalance, was presented as a
gendered form of power, and medications as the agents of a rather familiar form of
resolution.
I want to return, finally, to the cartoon Prozac basketball—an image that
has neither a wedding ring, nor a woman28—for a consideration of future in-
quiry. I have made an assumption in this paper that pharmaceutical advertisements
have been historically constructed for the viewership of a male audience, based
upon the structural configuration of many of the images, and the assumption of
a “male” spectator position. In the process, however, I have not considered the
responses that the increasing numbers of women psychiatrists might have had to
the advertisements, or the implications raised by the possibility that women view-
ers were asked to respond at all. At the same time, the current moment presents
another pressing concern with respect to female spectatorship: advertisements
specifically constructed to be viewed by women. Unlike their predecessors, con-
temporary psychotropic advertisements do not produce images for consumption
only by doctors, but by the readers ofCosmopolitan, Marie Claire, and other mag-
azines in which ads for Serafem, Prozac, and other medications predominantly
appear.
As I claim above, these direct-to-the-consumer (“DTC”) advertisements might
seem vague to the point of being unproblematic. However when considered within
the long history of images in which women such as Sue “return” to normative roles
over time, and more importantly within the context of women’s magazines inti-
mately concerned with “self improvement,” or ways to “feel more attractive,” or
“ways to catch a man,” the possibility arises that DTC advertisements tacitly raise
the threat of being “not normal”—whereby not normal means not attractive, and
not self-improved, and most importantly not able to attract a man. When coupled
with the implicit message that drugs like Prozac might help achieve such a state, it
suggests that these advertisements might be cueing women readers of these popular
magazines to provide the other half of a historically developed discussion. These
images might in other words seek to have their viewers ask the very same ques-
tions that their doctors have already been prepared to hear—or more appropriately,
to see.
28The image fits into the narrative I am describing: it begins in a post-Prozac moment in which Sue
plays with her kids “again,” and after the treatment has taken place.
P1: FLT
Journal of Medical Humanities [jmh] PH162-jomh-454188 November 23, 2002 16:29 Style file version June 4th, 2002
102 Metzl
REFERENCES
Alexander, F., & Selesnick, S. (1966).The history of psychiatry.New York: Harper.
Altschule.(1953).Body physiology in mental and emotional disorders.New York: Grune.
Ayd, F. (1991). The early history of modern psychopharmacology.Neuropsychopharmacology, 5(2),
71–84.
Balter, M. et al. (1974).Cross-national study of the extent of anti-anxiety/sedative drug use.New
England Journal of Medicine, 290,769–774.
Cant, G. (1976, Feb.1). Valiumania.New York Times Magazine, 34–54.
Chambers, C. (1972). An assessment of drug use in the general population. In J. Sussman (Ed.),Drug
use and social policy(pp. 50–61). New York: AMS Press.
Cooley, D. (1956, January). The new nerve pills and your health.Cosmopolitan, p. 70.
Friedan, B. (1963).The feminine mystique. New York: W. W. Norton.
Corrodi, H. et al. (1967). The effect of some psychoactive drugs on central monoamine neurons.
European Journal of Pharmacology, 1, 363–368.
Courtney, A., & Whipple, T. (1983).Sex stereotype in advertising.Massachussetts: Lexington Books.
Douglas, S. (1994).Where the girls are: Growing up female with the mass media. New York: Times
Books.
Garb, T. (1993). Gender and representation. In F. Frascina (Ed.),Modernity and modernism: French
painting in the nineteenth century(pp. 219–290). New Haven: Yale University Press.
Goffman, E. (1979).Gender advertisements.London: Macmillan Press.
Hawkins, J.W., & Aber, C.S. (1988). The content of advertisements in medical journals: Distorting the
image of woman.Women and Health, 14(2), 45.
Hayle, N.G. Jr. (1995).The rise and crisis of psychoanalysis in the United States: Freud and the
Americans, 1917–1985. New York:
Healey, D. (1997).The antidepressant era. Cambridge: Harvard University Press.
Johnson, J. (1973).Lesbian nation: The feminist solution.New York: Simon and Schuster.
Josephson, S. (1996).From idolatry to advertising: Visual art and contemporary culture. New York:
M.E. Sharpe.
Koedt, A. (1971). Lesbianism and feminism.Notes from the third year: Women’s liberation.New York:
Radical Feminists.
Kramer, P. (1994).Listening to Prozac.New York: Penguin.
Levy, R. (1994). The role and value of pharmaceutical marketing.Archives of Family Medicine. 3,
327–332.
Listening to Eli Lilly. (1994, March 31).Wall Street Journal, B-1.
Manheimer, D. et al. (1968). Psychotherapeutic drugs.California Medicine, 109,445–451.
Merriam, E. (1958, Nov. 8). The matriarchal myth, or The case of the vanishing male.The Nation,
331–5.
Mulvey, L (1981). Afterthoughts. . . Inspired by “Duel in the Sun.” Framework, 15–17, 12–15.
Nathanson, C. (1980). Social roles and health status among women: The significance of employment.
Social Science and Medicine, 16,1781–1789.
Parry H., et al. (1973). National patterns of psychotherapeutic drug use.Archives of General Psychiatry,
28,769–738.
Parry, H. (1968). Use of psychotropic drugs by U.S. adults.Public Health Reports, 83,799–810.
Special report: Women in revolt. (1970, Mar. 23).Newsweek, 70.
Propp, V. (1968).Morphology of the folktale.Austin: University of Texas Press.
The American male: Why do women dominate him. (1959, March).Look, 40–45.
The new feminists: Revolt against sexism. (1969, Nov. 21).Time, 53–56.
The personality pill. (1993, Oct. 1).Time, 53.
The promise of prozac. (1990, Mar. 26).Newsweek, 39.
The politics of sex: Kate Millet of women’s lib. (1977, Aug. 31).Newsweek, 31.
Schlessinger Jr., A. (1959, Jan.). The crisis in American masculinity.Esquire, 69–75.
Smith, M.C. (1985).Small comfort: A history of the minor tranquilizers.New York: Praeger.
Thompson, E. (1979). Sexual bias in drug advertisements.Social Science and Medicine, 13A,187–
191.
P1: FLT
Journal of Medical Humanities [jmh] PH162-jomh-454188 November 23, 2002 16:29 Style file version June 4th, 2002
Selling Sanity Through Gender 103
Unsettling facts about the tranquilizers. (1958, Jan.).Consumer Reports, 4.
Wallerstein, R.S. (1991). The future of psychotherapy.Bulletin of the Menninger Clinic, 55, 421–
443.
Wallis, C. (1989, Dec. 4). Onward women!Time, 81–89.
Wong, D.T. et. al. (1974). A selective inhibitor of serotonin uptake.Life Sciences, 15,471–79.
Wylie, P. (1955).Generation of vipers.2nd ed. New York: Pocket Books.
